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ORIGINAL ARTICLE
Peripheral leukocyte analysis is a common and
easily performed laboratory examination in clin-
ical fields. The currently used reference range for
peripheral total leukocyte count is relatively wide:
4.5–11.0 × 109/L in new editions of Harrison’s
Principles of Internal Medicine,1 Cecil’s Essentials of
Medicine,2 and Hematology: Basic Principles and
Practice,3 and 4.0–11.0 × 109/L in the new edition
of Postgraduate Haematology.4 Such wide reference
ranges for total leukocyte count are associated
with a low sensitivity in identifying abnormal
health conditions, limiting the clinical importance
and usefulness of peripheral leukocyte analysis.
In the past decade, many non-infectious health
problems have been found to be associated with
an increase in peripheral total leukocyte count,5–15
Revision in Reference Ranges of Peripheral
Total Leukocyte Count and Differential
Leukocyte Percentages Based on a Normal
Serum C-Reactive Protein Level
Zei-Shung Huang,1 Shyh-Chyi Lo,2 Woei Tsay,1 Kwan-Lih Hsu,1 Fu-Tien Chiang2*
Background/Purpose: A higher total leukocyte count is a predictor of all-cause mortality and cardiovascular
morbidity. The currently used reference range for peripheral total leukocyte count is wide (4.5–11.0 × 109/L)
and is associated with a low sensitivity in identifying non-infectious chronic diseases. We attempt to revise
it based on a normal serum C-reactive protein (CRP) level.
Methods: Study subjects were participants in a health check program at our hospital between 2000 and
2002. Those whose leukocyte analysis had been checked with the Sysmex Cell Counter NE-9000 were 
enrolled.
Results: Significantly positive relationships between CRP level and total leukocyte count, neutrophil per-
centage, and monocyte percentage were found in all subjects (n = 14,114; p < 0.0001). In contrast, CRP
level had a significantly inverse correlation with lymphocyte percentage (p < 0.0001). A proposed new ref-
erence range for total leukocyte count was estimated based on the data in the normal CRP level group
(CRP<0.1 mg/dL; n=4839). To rest on the essence of statistics that the range of [mean±2 standard deviations]
contains approximately the middle 95% of observations in a sampled population, a new reference range
for total leukocyte count was accordingly estimated to be 3.11–8.83 × 109/L.
Conclusion: In view of the abundant evidence showing that a higher peripheral total leukocyte count is
harmful to health, a down-correction of its upper reference range from the currently used 11.0 × 109/L to
the proposed 8.83 × 109/L, based on a normal CRP level, should allow more abnormal health conditions
to be identified and promote the usefulness of peripheral leukocyte analysis. [J Formos Med Assoc 2007;
106(8):608–616]
Key Words: atherosclerosis, leukocyte count, reference range, serum CRP level
©2007 Elsevier & Formosan Medical Association
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Departments of 1Internal Medicine and 2Laboratory Medicine, College of Medicine and Hospital, National Taiwan University, Taipei,
Taiwan.
Received: January 5, 2007
Revised: February 15, 2007
Accepted: May 1, 2007
*Correspondence to: Dr Fu-Tien Chiang, Department of Laboratory Medicine, College of Medicine and
Hospital, National Taiwan University, 7 Chung-Shan South Road, Taipei 100, Taiwan.
E-mail: futienc@ntuh.gov.tw
New reference ranges for leukocyte counts based on CRP level
J Formos Med Assoc | 2007 • Vol 106 • No 8 609
including hypertension,6,7,12 hypertriglyceride-
mia,8–10 obesity,8,9,11,12 smoking,8,12–15 lower
serum high-density lipoprotein level,9,10,12 and
higher insulin resistance or higher plasma in-
sulin concentration.10–12 These findings indicate
that the real normal range of total leukocyte
count should be lower than the currently used
reference range. A revision of the reference range is
needed for easier recognition of non-infectious
health problems. Studies have reported that the
aforementioned non-infectious health issues are
mainly associated with increases in neutrophil
and monocyte counts.7,8 The reference ranges for
differential leukocyte percentages should therefore
also be revised.
A further reason that demands a revision of the
reference range for total leukocyte count is accu-
mulating evidence that shows that a higher total
leukocyte count, even within normal limits, is an
independent predictor of all-cause mortality16–20
and a significant risk factor or predictor for car-
diovascular morbidity.12,13,16,17,21–24 Possible ex-
planations include, firstly, that a higher total
leukocyte count may reflect the existence of clin-
ical or subclinical in vivo harmful inflammatory
activity; secondly, many of the aforementioned
non-infectious health problems associated with
a higher total leukocyte count are documented
risk factors for cardiovascular diseases;9,10,21 and
thirdly, a higher total leukocyte count may be part
of the causal chain that leads to atherosclerosis
and ischemic arterial diseases.22–25
A major difficulty in any revision of the ex-
isting reference range for total leukocyte count 
is determining criteria. In this group’s opinion, 
a normal serum C-reactive protein (CRP) level is
adequate for this purpose: both CRP level and
total leukocyte count are well documented in the
literature as robust inflammatory indicators.26–29
In theory, CRP level and total leukocyte count may
reflect the presence and degree of overall inflam-
matory activity in the body in parallel. Therefore,
in this retrospective study, a normal CRP level was
used as the basis on which the reference ranges for
total leukocyte count and differential leukocyte
percentages in peripheral blood were revised.
Patients and Methods
Study subjects
Subjects were selected from participants in a health
check program at our hospital between January 1,
2000 and December 30, 2002. The participants
of the health check program were enrolled in the
study according to the following conditions: (1)
the results of peripheral leukocyte analysis and
serum CRP level (mg/dL) were available, and (2)
peripheral leukocyte analysis was checked with
the same blood cell counter (Sysmex Cell Counter
NE-9000; TOA Medical Electronics Co. Ltd., Kobe,
Japan). The purpose of the second condition was
to increase the accuracy and reliability of the re-
sults of leukocyte count analysis. CRP level was
measured using the IMMAGE Immunochemistry
System (Beckman Coulter Inc., Fullerton, CA,
USA). For those who received more than one
health check during the study period, only data
from the first health check was used.
Laboratory data
For the enrolled subjects, data on age, gender,
CRP level, and peripheral leukocyte analysis were
obtained from the computer database of our
Health Check Department. The leukocyte analy-
sis included total leukocyte count (109/L) and
differential percentages (%) of neutrophils, lym-
phocytes, monocytes, eosinophils, and basophils.
The differential percentages of these five types of
leukocytes added up to 100%. The absolute count
of a leukocyte subtype was calculated as the prod-
uct of its respective differential percentage and
total leukocyte count.
Statistical analysis
In all subjects, the relations between CRP level
and total leukocyte count and differential leuko-
cyte percentages were analyzed using both linear
correlation analysis by Pearson’s method (Table 1)
and regression analysis by the least squares method
adjusted for age and sex (Table 2). Subjects were
further divided into five groups according to CRP
level as follows: group 1, CRP level < 0.1 mg/
dL; group 2, CRP level between 0.1mg/dL and
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0.29mg/dL; group 3, CRP level between 0.3 mg/
dL and 0.49 mg/dL; group 4, CRP level between
0.5 mg/dL and 0.99 mg/dL; group 5, CRP level
≥ 1.0 mg/dL. In these five groups, the means ±
standard deviations (SDs) of total leukocyte count,
differential leukocyte percentages, and differential
leukocyte counts were estimated and compared
using analysis of variance (ANOVA) (Table 3).
A new reference range for total leukocyte count
was proposed, based on the data in the normal
CRP group (n = 4839), according to the essence of
statistics that the range of [mean ± 2 SDs] contains
approximately the middle 95% of the individual
observations in a sampled population. Using the
mean and SD of total leukocyte count in the nor-
mal CRP group, the proposed new reference range
Table 1. Linear correlations between serum C-reactive protein (CRP) level and peripheral total leukocyte count and differential
percentages
Total leukocyte count Differential leukocyte percentage (%)
(109/L) Neutrophils Lymphocytes Monocytes Eosinophils Basophils
Serum CRP level (mg/dL)
All subjects (n=14,114) 0.1462 0.1762 −0.1873† 0.0539 −0.0364 −0.0442
(p value*) < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
Age ≥ 50 yr (n = 8022) 0.1434 0.1816 −0.1884 0.0382 −0.0446 −0.0277
(p value*) < 0.0001 < 0.0001 < 0.0001 < 0.001 < 0.0001 < 0.05
Age < 50 yr (n = 6092) 0.1745 0.1662 −0.1833 0.0799 −0.0460 −0.0562
(p value*) < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.001 < 0.0001
All men (n = 8134) 0.1304 0.1838 −0.1939 0.0629 −0.0507 −0.0237
(p value*) < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.05
All women (n = 5980) 0.1788 0.1721 −0.1822 0.0349 −0.0407 −0.0630
(p value*) < 0.0001 < 0.0001 < 0.001 < 0.01 < 0.01 < 0.0001
*Probability values were calculated for correlations between serum CRP level and respective leukocyte parameters; †the “−” before a correlation coefficient
indicates an inverse relationship.
Table 2. Regression analyses of total leukocyte count and differential percentages in relation to age, gender, and serum 
C-reactive protein (CRP) level (n = 14,114)
Total leukocyte count (109/L) Neutrophils (%) Lymphocytes (%)
Regression coefficient 
p*
Regression coefficient
p*
Regression coefficient
p*
(SE)* (SE)* (SE)*
Age (yr) −0.0173 (0.0010) < 0.0001 0.0646 (0.0058) < 0.0001 −0.0740 (0.0053) < 0.0001
Gender† −0.4016 (0.0260) < 0.0001 0.5597 (0.1453) = 0.0001 0.9239 (0.1346) < 0.0001
Serum CRP (mg/dL) 0.4588 (0.0243) < 0.0001 2.7948 (0.1361) < 0.0001 −2.7348 (0.1261) < 0.0001
Monocytes (%) Eosinophils (%) Basophils (%)
Regression coefficient
p*
Regression coefficient
p*
Regression coefficient 
p*
(SE)* (SE)* (SE)*
Age (yr) 0.0046 (0.0012) < 0.0001 0.0039 (0.0015) < 0.01 0.0009 (0.0002) < 0.0001
Gender† −0.5859 (0.0297) < 0.0001 −0.8685 (0.0366) < 0.0001 −0.0293 (0.0059) < 0.0001
Serum CRP (mg/dL) 0.1657 (0.0278) < 0.0001 −0.2001 (0.0343) < 0.0001 −0.0257 (0.0055) < 0.0001
*Regression coefficients were estimated by the least squares method and probability values were calculated by t test; †in the statistical analysis, female and
male were represented digitally by 0 and 1, respectively. SE = standard error.
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would be between [mean – 2 SDs] and [mean +
2 SDs]. The obtained data are shown in Table 4.
Results
Correlations between CRP level and
leukocyte parameters
In total, 14,114 subjects (8134 men, 5980 women)
were enrolled into the study. The age of all subjects
ranged from 15 to 90 years, with a median of 
51 years and a mean of 51.53 years. The age of the
men ranged from 15 to 90 years, with a median
of 52 years and a mean of 51.73 years. The age 
of the women ranged from 15 to 90 years, with 
a median of 51 years and a mean of 51.26 years.
Table 1 shows the linear correlations between
serum CRP level and total leukocyte count (109/L)
and differential leukocyte percentages (%), sepa-
rately analyzed for all subjects, two different age
Table 3. Means (± standard deviations) of total leukocyte count and differential percentages in the five groups with different
serum C-reactive protein (CRP) levels
Total leukocyte count Differential leukocyte percentage (%)
(109/L) Neutrophils Lymphocytes Monocytes Eosinophils Basophils
Serum CRP level (mg/dL)
< 0.1 (n = 4839) 5.97 ± 1.43 52.08 ± 8.39 36.93 ± 7.83 6.97 ± 1.72 3.45 ± 2.22 0.57 ± 0.35
0.1–0.29 (n = 5482) 6.26 ± 1.48 53.07 ± 8.34 36.05 ± 7.80 6.89 ± 1.66 3.43 ± 2.15 0.57 ± 0.34
0.3–0.49 (n = 2419) 6.51 ± 1.61 54.28 ± 8.53 34.80 ± 7.89 6.93 ± 1.80 3.42 ± 2.23 0.57 ± 0.36
0.5–0.99 (n = 983) 6.81 ± 1.79 56.18 ± 9.36 32.83 ± 8.56 7.18 ± 2.13 3.29 ± 2.14 0.53 ± 0.32
≥ 1.0 (n = 391) 7.27 ± 2.34 61.39 ± 10.39 27.62 ± 9.17 7.48 ± 2.44 3.01 ± 2.15 0.50 ± 0.33
p value* < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0005 < 0.0001
*Probability values for testing the difference among the five groups of different serum CRP levels were calculated using one-way ANOVA.
Table 4. Comparison of the currently used and the proposed new reference ranges for total leukocyte count and differential
percentages/counts
Reference ranges
Total leukocyte count Leukocyte percentage (%)
(109/L) Neutrophils Lymphocytes Monocytes Eosinophils Basophils
This study* 3.11–8.83 35.3–68.9 21.3–52.6 3.53–10.4 0–7.89 0–1.27
Our hospital in 2006 4.0–11.0 40–76 20–45 2–10 1–6 0–1
Harrison’s Medicine1 4.5–11.0 40–70 22–44 4–11 0–8 0–3
Cecil’s Medicine2 4.5–11.0 57–67 23–33 3–7 1–3 0–0.75
Hematology3 4.5–11.0 59 34 4 3 (–)
Postgraduate Haematology4 4.0–11.0 (–) (–) (–) (–) (–)
Leukocyte count (109/L)
Neutrophils Lymphocytes Monocytes Eosinophils Basophils
This study* 1.06–5.22 0.94–3.42 0.170–0.650 0.000–0.500 0.000–0.075
Our hospital in 2006 (–) (–) (–) (–) (–)
Harrison’s Medicine1 (–) (–) (–) (–) (–)
Cecil’s Medicine2 3.15–6.20 1.50–3.00 0.285–0.500 0.05–0.25 0.15–0.50
Hematology3 1.8–7.7 1.0–4.8 (–) (–) (–)
Postgraduate Haematology4 2.5–7.5 1.5–3.5 0.2–0.8 0.04–0.44 0.01–0.1
*According to the essence of statistics, the range of [mean ± 2 standard deviations] contains approximately the middle 95% of observations in a sampled
population. The new reference ranges for leukocyte parameters were thus estimated to be between [mean – 2 SDs] and [mean + 2 SDs], using data from
the normal serum CRP level group (CRP < 0.1 mg/dL, n = 4839; see Table 3 and Results section). SD = standard deviation; CRP = C-reactive protein.
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groups (≥ 50 years old and < 50 years old), and
the two gender groups. There were persistent sig-
nificantly positive correlations between serum
CRP level and total leukocyte count (all p <
0.0001), neutrophil percentage (all p < 0.0001),
and monocyte percentage (all p < 0.001, except for
the female group, which was p < 0.01). In con-
trast, CRP level had significantly inverse correla-
tions with lymphocyte percentage (all p < 0.0001,
except for the female group, which was p < 0.001),
eosinophil percentage (all p < 0.001, but p < 0.01
in female group), and basophil percentage (all
p < 0.0001, but p < 0.05 in male group and in
older age group). These results indicate that when
a normal serum CRP level (< 0.1 mg/dL) is em-
ployed as the basis for revising reference ranges,
there will be a lower total leukocyte count, mainly
due to the lower neutrophil and monocyte counts.
The regression analyses of total leukocyte count
and differential leukocyte percentages in relation
to age, gender, and serum CRP level for all subjects
are listed in Table 2. The results were consistent
with those given in Table 1. In brief, after adjust-
ing for age and gender, significantly positive cor-
relations persisted between serum CRP level and
total leukocyte count, neutrophil percentage, and
monocyte percentage (all p < 0.0001), and there
were significantly inverse correlations between
serum CRP level and lymphocyte, eosinophil and
basophil percentages (all p < 0.0001).
Means of leukocyte parameters in normal
CRP group
The means ± SDs of total leukocyte count and
differential leukocyte percentages of the normal
serum CRP group and the other four groups of
higher serum CRP level are shown in Table 3.
The means of the total leukocyte count, neutrophil
percentage, and monocyte percentage were low-
est in the normal CRP level group, and increased
steadily in groups of higher serum CRP levels (all
p < 0.0001 by ANOVA). In contrast, the means of
lymphocyte, eosinophil, and basophil percentages
were highest in the group with normal CRP level
and decreased steadily in the groups of higher
serum CRP levels (all p < 0.0005).
Figure 1 shows the trends in the means of 
the total leukocyte, neutrophil, lymphocyte, and
monocyte counts in the five groups of different
serum CRP levels. There were positive correla-
tions between serum CRP level and the counts 
of total leukocytes, neutrophils and monocytes
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Figure 1. Trends in the means of total leukocyte, neutrophil, lymphocyte, and monocyte counts in the five groups with
different serum C-reactive protein (CRP) levels. There were significantly positive correlations between serum CRP level and
the counts of total leukocytes, neutrophils and monocytes (all p<0.0001 by one-way ANOVA). On the contrary, lymphocyte
count had a significantly inverse correlation with serum CRP level (p < 0.0001).
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(all p < 0.0001 by one-way ANOVA). On the con-
trary, lymphocyte count had an inverse relation
with serum CRP level (p < 0.0001), with an obvi-
ous decrease in the two groups with the highest
serum CRP levels. Figure 2 shows the distribu-
tion of total leukocyte count in the 4839 subjects
with normal serum CRP level.
New reference ranges for leukocyte parameters
Using the mean and SD of total leukocyte count
in the group with normal serum CRP level (Table
3), its new upper reference margin was estimated
to be equal to [mean + 2 SDs] = [5.97 + (1.43 ×
2)] = 8.83 × 109/L, and its lower reference margin
to [mean – 2 SDs] = [5.97 – (1.43 × 2)] = 3.11 ×
109/L. Accordingly, the new reference range for
total leukocyte count was determined to be 3.11–
8.83 × 109/L. In a similar way, the new reference
ranges for the other leukocyte parameters were
estimated and compared with the currently used
reference ranges,1–4 and they are shown in Table 4.
Discussion
The results showed that subjects with normal
serum CRP level (< 0.1 mg/dL) were associated
with a lower peripheral total leukocyte count,
lower percentages of neutrophils and monocytes,
and higher percentages of lymphocytes, eosino-
phils and basophils when compared with sub-
jects with higher serum CRP levels (Tables 1–3).
Based on [mean ± 2 SDs] of the total leukocyte
count in the normal serum CRP group (Table 3),
a proposed new reference range for total leuko-
cyte count was estimated to be 3.11–8.83 × 109/L.
The upper margin of this proposed reference range
(8.83 × 109/L) is prominently lower than the cur-
rently used upper margin of 11.0 × 109/L.1–4 It is
asserted that such a down correction of the upper
reference margin of total leukocyte count will 
improve the identification of abnormal health con-
ditions. This hypothesis is supported by accumu-
lated evidence in the literature as detailed below.
The Normative Aging Study, with 18 years of
follow-up, found that mortality rates for men
with baseline white blood cell count > 9.0 × 109/L
were 1.8–2.5 times greater than those of men
with a lower white blood cell count.18 It was also
found that baseline total leukocyte count was an
independent predictor of mortality, even when
within the reference range. An elevation of 1.0 ×
109/L in count increased the risk ratio 1.2-fold. A
total leukocyte count > 9.0 × 109/L, close to the
proposed upper reference margin of 8.83 × 109/L
in our study, is therefore harmful to health.
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Figure 2. Distribution of 
total leukocyte count in the
4839 subjects with normal
serum C-reactive protein level
(< 0.1 mg/dL).
The NHANES I Epidemiologic Follow-up Study
of 7–16 years found that Caucasian men with a
total leukocyte count > 8.1 × 109/L had an in-
creased risk of coronary heart disease, with a risk
ratio of 1.31 compared with those with a total
leukocyte count < 6.6 × 109/L.17 In white women
aged 45–74 years, the risk ratio was 1.31 after ad-
justment for baseline risk factors. For all-cause
mortality in males aged 45–74 years, subjects with
an upper stratum of total leukocyte count had a risk
ratio of 1.43 compared with those with a lower
stratum of total leukocyte count. Subjects who had
never smoked had a risk ratio of 1.33 after adjust-
ment for baseline risk factors. It can, therefore, be
reasoned that a total leukocyte count > 8.1 × 109/L,
slightly lower than the upper reference margin of
8.83×109/L in our study, is harmful to health.
A community study of African-Americans
found that subjects with a total leukocyte count
≥ 7.0 × 109/L had a 1.9-fold risk of cardiovascular
morbidity and a 2.3-fold risk of cardiovascular
mortality compared with those with total leuko-
cyte count < 4.8 × 109/L. Such associations were
similar in Caucasians and in people who had
never smoked.30 These findings suggest that the
real upper margin of normal total leukocyte count
may be even lower than the proposed upper
margin of 8.83 × 109/L in our study.
In different countries and among different races,
the reference ranges for total leukocyte count
and differential leukocyte percentages may differ.
A survey study in 2001, of data on native Chukotka
adults aged > 25 years and a non-organized pop-
ulation of the same age in Novosibirsk, found
that the middle 10–90% range of total leukocyte
count of the former was lower than the latter
(3.0–7.0×109/L vs. 4.0–9.0×109/L, respectively).31
Among our subjects with normal serum CRP
level, the 10–90% distribution interval of the
total leukocyte count was 4.57–7.39 × 109/L.
In a recent paper on the interpretation of abnor-
mal complete blood cell count in adults reviewed
by the Mayo Clinic,32 the following reference
ranges for total leukocyte count in the following
different categories were shown: white male,
3.6–9.2 × 109/L; white female, 3.5–10.8 × 109/L;
male of African ancestry, 2.8–7.2 × 109/L; female
of African ancestry, 3.2–7.8 × 109/L. These figures
were abstracted from population-based studies
from Bain33 and NHANES-II.34 The reference range
used by the Mayo Clinic in 2005 was 3.5–10.5 ×
109/L for both genders,31 which is slightly lower
than the 4.0–11.0 or 4.5–11.0 × 109/L in the afore-
mentioned prominent medical textbooks.1–4
An interesting finding in our study was that
when a normal serum CRP level was employed
as a basis for revising reference ranges, a higher
differential lymphocyte percentage was found to
be associated with a lower total leukocyte count
(Table 4). This is mainly secondary to the lower
neutrophil and monocyte percentages that are asso-
ciated with a normal serum CRP level (Table 3).
A further finding worthy of special mention is
the new lower reference margin for total leuko-
cyte count. According to the currently used refer-
ence range, a value < 4.0 × 109/L is defined as
leukopenia. In this author’s experience, a total
leukocyte count of 3.0–4.0 × 109/L is occasionally
detected in patients without clinical evidence of
infectious or hematologic disease. For such pa-
tients, consultant hematologists usually suggest
only regular follow-up of leukocyte analysis. Bone
marrow study is indicated only if the count be-
comes lower than 3.0×109/L or if clinical evidence
of hematologic disease is present. The empirical
value of this hospital’s hematologists is lower
than the proposed lower margin of 3.11 × 109/L
in our study, suggesting that the down-correction
of the lower reference margin for peripheral total
leukocyte count in our study may be adequate.
However, although there is abundant evidence
to show a significant link between higher serum
CRP level and higher peripheral total leukocyte
count,26–29,35 the link between serum CRP level
and leukopenia is complex and inconsistent. In
autoimmune disease-induced leukopenia, for ex-
ample, a higher serum CRP level may be present
due to an active autoimmune process.36,37 Such
a higher serum CRP level may become lower and
come within normal limits when circulating 
autoantibody against CRP molecules exists,38,39
or when circulating CRP molecules have been
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largely consumed during its biological protective
action against the pathologic process of autoim-
munity.39–41 This information from the literature
suggests that the revision of the lower reference
margin for peripheral total leukocyte count based
on a normal serum CRP level is of limited value.
Fortunately, this issue is not the primary purpose
of our study.
Another weak point of our study is that al-
though both serum CRP level and peripheral
total leukocyte count are reliable indicators of
inflammatory activity,26–29 certain diseases have
diverse effects on these two indicators. In hema-
tologic malignancy such as leukemia and lym-
phoma, for example, leukocytosis due to abnormal
leukocyte production may be associated with a
normal serum CRP level in the absence of infec-
tion.42–44 In human immunodeficiency virus dis-
ease, as a contrary example, the commonly existing
mild leukopenia, due to virus-induced bone mar-
row suppression,45–47 is often associated with a
higher serum CRP level due to both the virus-
induced active disease process and the presence
of secondary infection.48,49 These special situa-
tions should be taken into consideration when
the results of this study are applied.
In conclusion, a revision of the upper refer-
ence range for peripheral total leukocyte count
based on a normal serum CRP level appears rea-
sonable and has obtained a practical result in
this study. In view of the abundant literature evi-
dence showing that a higher total leukocyte count
is harmful to health,16–24,30 a down-correction of
the upper reference range from the currently used
11.0 × 109/L to the proposed 8.83 × 109/L in this
study should allow more abnormal health con-
ditions to be identified and promote the use-
fulness of peripheral leukocyte analysis in both
clinical and epidemiologic fields.
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